Endometrial stromal sarcoma presenting as multiple primary tumor

Rajiv Kumar Saxena, Gurpreet Singh Sandhu, Karimbanamalayil Madhavi Babu

Department of Obstetrics and Gynaecology, 12 Air Force Hospital, Gorakhpur, India.
Department of Obstetrics and Gynaecology, Command Hospital Air Force, Bangalore, India.
Department of Obstetrics and Gynaecology, Vydehi Institute of Medical Sciences, Bangalore, India.

DOI: 10.4236/ojog.2013.31013                

Abstract

Endometrial Stromal Sarcoma (ESS) is a rare uterine malignancy. The annual incidence of ESS has been reported as 1 - 2 per million women. In the general population approximately 10 percent of cancer patients may develop a second primary cancer. Synchronous multiple primary tumors constitute only 20% of all multiple primary tumors, and by definition, occur within a period of two month. This case report is presented to document the occurrence of ESS as a “Synchronous Multiple Primary Tumor”, which is an extremely rare event. Previously only one case report has documented such an occurrence. The literature is also briefly reviewed. This case underlines the requirement of a thorough initial evaluation for a patient with a gynecological malignancy and a regular follow-up. Follow-up includes patient education regarding symptoms of any recurrence, physical examination repeated at 6 - 12 monthly interval, along with imaging studies when indicated.

Keywords

Endometrial Stromal Sarcoma; Synchronous Multiple Primary Tumour; Invasive Ductal Breast

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Kiyozuka, Y., Yamamoto, M., Matsuyama, T., Miki, K., Tsukamoto, R., Shimano, N. and Tsubura, A. (2006) Synchronous granular cell tumor of the bladder, endometrial carcinoma and endometrial stromal sarcoma. Asia-Pacific Journal of Clinical Oncology, 2, 64-67. doi:10.1111/j.1743-7563.2006.00039.x
[2]	Boardman, C.H., Webb, M.J. and Jefferies, J.A. (2000) Low-grade endometrial stromal sarcoma of the ectocervix after therapy for breast cancer. Gynecologic Oncology, 79, 120-123. doi:10.1006/gyno.2000.5893
[3]	Pink, D., Lindner, T., Mrozek, A., Kretzschmar, A., Thuss-Patience, P.C., Dorken, B. and Peter, R. (2006) Harm or bene-fit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: Single center experience with 10 cases and review of the literature. Gynecologic Oncology, 101, 464-469. doi:10.1016/j.ygyno.2005.11.010
[4]	Howe, H.L. (2003) A review of the definition for multiple primary cancers in the United States. Workshop Proceedings, Spring-Field (IL): North American Association of Central Cancer Registries, 4-6 December 2002, Princeton.
[5]	Harlow, B.L., Weiss, N.S. and Lofton, S. (1986) The epidemiology of sarcomas of the uterus. Journal of the National Cancer Institute, 76, 399-402.
[6]	(2012) NCCN clinical practice guidelines in oncology. http://www.nccn.org/professionals/ physician_gls/pdf/uterine.pdf
[7]	Schenker, J.G., Levinsky, R. and Ohel, G. (1984) Multiple primary malignant neoplasms in breast cancer patients in Israel. Cancer, 54, 145-150. doi:10.1002/1097-0142(19840701)54:1<139::AID-CNCR2820540129>3.0.CO;2-U